Ping W. is a seasoned gene and cell therapy professional with extensive experience in E2E process development and clinical research within biotechnology, CDMO, and academia. They have held various roles, including Senior Scientist at Catalent, where they lead CAR-T process development, and Associate Principal Scientist at WuXi Advanced Therapies, focusing on cell therapy. Ping previously contributed as a Senior Research Associate at OriGene Technologies and as a Scientist at Cabaletta Bio, specializing in lentivirus manufacture and CAART process development. They earned their Doctor of Medicine from China Medical University and a PhD in Molecular Biology from Kobe University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices